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 Type I diabetes is caused by selective loss of insulin-producing β-cells.  Identifying 
and activating an endogenous source of new β-cells could be used to replenish those lost 
in this disease.  The nature and existence of an adult pancreatic stem/progenitor cell 
population, however, is still controversial.  Circumstantial evidence indicates that islet 
cells arise from embryonic ductal cells.  In contrast, the majority of adult islet cells 
appear to regenerate via self-renewal during postnatal expansion and adult homeostasis.  
That ducts could also give rise to new beta-cells in the adult (neogenesis) was recently 
suggested in the context of pancreatic ductal ligation (PDL) injury.  The Notch signaling 
pathway inhibits islet development and promotes progenitor cell maintenance during 
early pancreatic organogenesis, acting primarily through its target gene Hes1.  While 
Hes1 is broadly expressed in the embryonic pancreas, only rare Hes1-expressing cells can 
be found in the adult organ, among mature ducts and centroacinar cells (CACs), the latter 
of which have been proposed to represent adult progenitors.  This thesis aims to test 
directly the ability of duct cells to generate islet cells, and to determine the biological 
function of Hes1+ duct cells.  For this, we performed lineage tracing and genetic 
manipulation using two novel Cre-lines, Muc1IC2, which marks exocrine cells, and 
Hes1C2, which marks Hes1+ cells.  Our work has uncovered three major phases in the 
development of pancreatic islet cells: (i) initially, new islet cells originate from Notch-
responsive exocrine cells, (ii) later in embryogenesis, Notch signaling needs to be down-
iv 
regulated in exocrine cells for islet neogenesis to proceed and (iii) from birth onwards, 
islet cells are maintained by replication of pre-existing cells with no detectable influx 
from neogenesis.  Additionally, our findings demonstrated that early Hes1+ cells 
represent multipotent progenitors and that their immature state is maintained through 
active Notch signaling.  Interestingly, later in development Notch promotes duct 
specification of Hes1-expressing bipotent exocrine progenitors.  In the mature pancreas, 
Hes1 expression persists in Notch-sensitive centroacinar cells, which act as facultative 
exocrine-specific progenitor cells.  Thus, the research described in this thesis determines 
the identity of embryonic and adult pancreatic progenitor cells, and demonstrates that 
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 Type 1 diabetes results from the specific loss of insulin-producing beta (β)-cells, 
and therefore represents a candidate disease for cell replacement therapy.  
Transplantation of islets can serve as a potential cure for this disease.  The relatively low 
abundance of endogenous β-cells within the pancreas and the shortage of donor organs, 
however, makes finding new ways of generating functional β-cells a necessity.  One 
intriguing possibility to treat this disease is by generating new β-cells from an 
endogenous source.  Whether stem or progenitor cells exist in the adult pancreas, either 
dedicated to islet differentiation or recruited by injury, remains controversial.  
Histological evidence suggests that β-cells and other islet cells originate from multipotent 
progenitor cells within the embryonic ducts (a process termed neogenesis).  In contrast, 
genetic lineage tracing studies indicate that β-cells are maintained in the mature pancreas 
by self-renewal.  Recent evidence, however, suggest that new β-cells could also arise 
from duct cells following pancreatic injury.  Whether these cells represent terminally 
differentiated ducts or progenitors residing within the ductal network is still unknown. 
 The first half of this thesis focuses on the lineage relationship between ducts and 
islet cells during embryogenesis and adulthood, emphasizing two main questions: (1) 
What is the origin of the new β-cells that arise in large numbers shortly after birth? (2) Is 
2 
there any contribution to new islets from the exocrine tissue (duct and acinar cells) during 
adult homeostasis or regeneration?   
 The second half of this thesis addresses the question whether the pancreas 
contains an adult stem/progenitor cell.  Duct cells have been proposed to be the origin of 
new β-cells after injury, and centroacinar cells to represent adult progenitor cells.  The 
latter cell type has been shown to possess multilineage differentiation potential in vitro, 
but confirmation in vivo is still lacking.  The Notch signaling pathway is involved in 
maintenance of stem cells in several organs.  In the pancreas, Notch plays an important 
role in cell specification and differentiation in that it represses islet development and 
promotes progenitor cell maintenance during early pancreas organogenesis, acting 
primarily through its target gene Hes1.  Hes1 is broadly expressed in undifferentiated 
cells of the early pancreas, while in the adult it is expressed by scattered ductal and 
centroacinar cells.  This thesis seeks to elucidate (3) whether Hes1+ cells are multipotent 
throughout pancreatic organogenesis and (4) whether the rare Hes1+ cells in the mature 
pancreas represent adult progenitors similar to their embryonic counterparts.   
 By examining the extent to which ducts can contribute to new β-cells, we shed 
light on the question whether human ductal cells could serve as a source for beta-cell 
replacement therapy in type I diabetes.  Moreover, by studying the Notch pathway in 
closer detail, we now better understand its functions not only in development, but also in 
adult pancreatic disease.  This thesis also addresses fundamental biological questions 
about the relationship between embryonic development and adult homeostasis, applicable 
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EXOCRINE-TO-ENDOCRINE DIFFERENTIATION IS DETECTABLE 









































































MUC1+ EXOCRINE CELLS DO NOT CONTRIBUTE TO NEW β-CELLS  
 






Autoimmune destruction of insulin-producing beta (β)-cells from the pancreas 
results in type 1 diabetes.  Although lost β -cells in this disease can be replaced by islet 
transplantation, donor organs are scarce.  It is therefore widely hoped that adult exocrine 
tissue could serve as a new source for transplantable β-cells.  Indeed, this possibility has 
been aggressively pursued, through culture-based studies, for at least a decade (Baeyens 
et al., 2005; Bonner-Weir et al., 2000; Gao et al., 2005; Hao et al., 2006; Ramiya et al., 
2000; Yatoh et al., 2007).  These studies remain, however, largely inconclusive, since 
they are not supported by in vivo studies in the mouse, which indicate that adult β-cells 
are maintained by self-renewal rather than neogenesis (Brennand et al., 2007; Dor et al., 
2004; Nir et al., 2007; Teta et al., 2007).  On the other hand, experiments in vitro and 
injury models in vivo may provide as yet-unidentified signals sufficient to trigger 
neogenesis. 
Before discussing the possibility of injury-induced neogenesis, we will briefly 
consider the more settled question of where embryonic β-cells come from.  Descriptive 
studies suggested that islet cells arise from duct-like structures (Slack, 1995), and
37 
Neurogenin-3 (Neurog3), a transcriptional “master regulator” of endocrine development, 
is expressed by duct-localized, endocrine-restricted precursor cells (Gradwohl et al., 
2000; Gu et al., 2002; Johansson et al., 2007; Schonhoff et al., 2004; Schwitzgebel et al., 
2000).  This hypothesis was only recently proven to be correct through the development 
of novel duct-specific Cre lines allowing for lineage tracing of the embryonic ducts.  We 
and others demonstrated that embryonic islets indeed arise from Neurog3+ cells that 
reside and originate from within the ductal epithelium (Furuyama et al., 2011; Kopinke 
and Murtaugh, 2010; Kopp et al., 2011; Solar et al., 2009).  β-cell expansion and 
homeostasis in the adult, however, appear to be driven by proliferation of already-
differentiated β-cells (Bouwens and Rooman, 2005; Dhawan et al., 2007).  This is 
supported by lineage-tracing studies, using transgenic mice in which existing β-cells can 
be marked and followed (Brennand et al., 2007; Dor et al., 2004; Nir et al., 2007).  
Although these studies indicate that nearly all adult β-cells arise from pre-existing β-cells, 
even in certain injury contexts, they might miss low levels of neogenesis, below the level 
of sensitivity imposed by experimental error (Murtaugh and Kopinke, 2008).  A more 
robust approach would be to label exclusively exocrine ducts and acini prior to injury, 
and then determine if any labeled cells contribute to new β-cells -- in such a paradigm, 
even a very small number of neogenic cells would be detectable. 
More recently, compelling evidence has been provided to suggest the existence of 
β-cell neogenesis following injury induced by pancreatic duct ligation (PDL) (Wang et 
al., 1995; Xu et al., 2008).  The key features of this model are: (i) duct cells rapidly 
expand, while acini undergo apoptosis; (ii) the ligated (splenic) lobe experiences a rapid 
and sustained doubling of β-cell mass, while the rest of the organ is unaffected; (iii) this 
  38
increase in β-cell mass is accompanied by, and dependent on, reactivation of Neurog3 
expression in the ducts.  Nonetheless, definitive proof for a ductal origin of new β-cells 
post-PDL is still awaiting confirmation, since the necessary tools to perform lineage 
tracing of ducts have only recently been developed. 
 In this study, we aimed to address the open question of whether new β-cells can 
originate from the ductal epithelium following duct ligation injury.  After establishing 
this injury model in our laboratory, we combined our tamoxifen-inducible Muc1IC2 line 
with Cre-dependent reporter mice to perform rigorous lineage tracing of exocrine cells 
during PDL.  Our findings suggest that the source for new β-cells is independent of the 
Muc1+ exocrine population.  It further indicates that the origin must either be a Muc1-
negative duct cell or that neogenesis does not occur after PDL. 
 
 
Materials and methods 
 
Mice 
Muc1IC2 (Kopinke and Murtaugh, 2010), R26REYFP (Srinivas et al., 2001), 
R26RLacZ (Soriano, 1999) and Neurog3 EGFP  (Lee et al., 2002) mice have been described 
previously.  Tamoxifen (TM) was dissolved in corn oil and administered by oral gavage 
at doses of 10 mg.  All experiments were carried out according to institutional guidelines.  
Pancreatic duct ligations were performed as described (Kopinke et al., 2011).  In brief, 
after anaesthetization with isoflurane the abdomen was shaved and cleaned with iodine.  
After Bupivacaine (0.25%) injections along the incision site, we accessed the peritoneum 
via a horizontal incision in the upper-left abdomen, deflected the liver and isolated the 
stomach with a hemostat, gently exposed and immobilized the splenic pancreas with 
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forceps and cotton swab, and tied off the splenic lobe with a monofilament (5-0) suture, 
sparing the splenic vessels.  In sham-operated mice, we similarly exposed the pancreas, 
but returned it to the body cavity without ligation; these pancreata appeared completely 
normal (data not shown).  Buprenorphine (0.05 mg/kg) was administered subcutaneously 
every 12 hours for the first 72 hours postsurgery.  All animal procedures were approved 
by the Institutional Animal Care and Use Committee of the University of Utah.  
 
Tissue processing and histology  
Immunostaining and analysis were performed as previously described (Kopinke et 
al., 2011; Kopinke and Murtaugh, 2010).  The following primary antibodies were used: 
rat anti-cytokeratin-19 1:50 (Developmental Studies Hybridoma Bank), rat anti-E-
cadherin 1:2000 (Zymed), rabbit anti-GFP 1:4000 (Abcam), goat anti-GFP 1:2500 
(Rockland), guinea pig anti-glucagon 1:2500 (Linco), rabbit anti-glucagon 1:2500 
(Zymed), guinea pig anti-Insulin 1:2000 (Dako), rabbit anti-LacZ 1:2000 (Cappel) and 
guinea pig anti-Pdx1 1:10000 (Chris Wright, Vanderbilt University).  All secondary 
antibodies (raised in donkey) were obtained from Jackson Immunoresearch.  For 
quantifications, co-immunofluorescence was determined using the Analyze Particles 
function of ImageJ (NIH) and confirmed by eye in Adobe Photoshop as previously 







Successful recapitulation of pancreatic duct ligation injury 
Since we did not observe any contribution to new beta cells from Muc1-
expressing ducts during postnatal expansion or adult homeostasis (Kopinke and 
Murtaugh, 2010), we wanted to test the differentiation potential of ductal and acinar cells 
during PDL, an injury model suggested to induce β-cell neogenesis (Wang et al., 1995; 
Xu et al., 2008).   
Our initial goal was to faithfully reproduce the previously reported phenotype 
(Wang et al., 1995; Xu et al., 2008), which we achieved with the help of Dr. Courtney 
Scaife (Department of Surgery).  Using CD1 wild type mice, we defined PDL as 
successful when the portion distal to the ligation turned translucent, acinar tissue was lost 
and replaced by inflammatory and epithelial ductal-like cells, and more islets were 
present per ligated area compared to the control portion 7 days post-PDL (Fig. 4.1).  Our 
success rate was in the range of 40-50% and seemed inversely correlated with body 
weight, such that surgeries usually work in young and lean mice and almost always fail in 
older and heavier (>35 g) mice. 
Another key feature of PDL is re-expression of Neurog3+ cells within duct-like 
cells of the ligated portion.  We have attempted without success to detect such cells in our 
experimental specimens, using three different antibodies that readily detect Neurog3-
expressing cells in the embryonic pancreas.  It is possible that the levels of Neurog3 
expression are below the sensitivity threshold of our antibodies.  Interestingly, a recent 
study indicates that Neurog3 is expressed in differentiated islet cells (Wang et al., 2009), 






Figure 4.1. Pancreatic duct ligation.  Morphological characterization of unligated (A-
C) and ligated pancreatic lobes (D-F) from 8-week-old CD1 wild-type mice, 7 days after 
PDL injury.  (A-B) Control pancreata are of white color (A) and exhibit normal 
architecture with acinar cells (ac), islets (is) and ducts (du) by hematoxylin and eosin 
staining (B).  (D-E) After ligation, pancreatic tissue appears yellow and more translucent, 
such that individual islets become visible (D, arrowheads).  In addition, the ligated lobes 
have undergone complete replacement of acinar tissue by ductal-like epithelial structures 
(ep) with interspersed islets (E).  C and F are fields from a single section through an 
operated pancreas, capturing both the unligated (C) and ligated area (F).  E-cadherin 
(green) marks acinar and ductal tissue in the unligated pancreas, as well as the residual 
epithelial and ductal structures remaining after PDL.  The area occupied by insulin-











Figure 4.2. Re-expression of embryonic progenitor markers.  PDL was performed on 
8-week-old Neurog3EGFP/+ reporter mice, and EGFP expression (green) was analyzed 7 
days after injury.  (A-B) While weak Neurog3 expression can be detected only in islet 
cells (arrowheads) in the unligated portion, rare GFP+ cells can be found also in E-
cadherin+ (red) epithelial clusters (open arrowhead) after ligation.  (C) PDL injury also 
causes re-expression of the progenitor marker Pdx1 (red) within duct-like structures as 
well as within Neurog3+ cells (green, arrowhead).  Scale bars: A, 100 μm; B, 50 μm; C, 







hormone-positive cells (Gradwohl et al., 2000; Schwitzgebel et al., 2000).  In this study, 
detection of Neurog3 in adult islets was achieved using a Neurog3EGFP knock-in mouse in 
which GFP expression acts as a surrogate for Neurog3 activity (Lee et al., 2002).  To 
enhance our ability to detect rare or faintly-expressing Neurog3+ cells, we obtained 
Neurog3EGFP mice and performed PDL experiments using this strain (n=5).  As described 
by others (Wang et al., 2009), we could detect Neurog3 expression in islet cells within 
the unligated control area (Fig. 4.2A).  Neurog3+ cells could also be found in epithelial 
duct-like cells within the ligated portion, but at a very low frequency (Fig. 4.2B).  Duct 
ligation injury also caused more widespread up-regulation of another early progenitor 
marker, Pdx1, within the duct-like cells (Fig. 4.2C).   
These results demonstrate that our surgery technique is successful in 
recapitulating known hallmarks of PDL injury.  During pancreas development, all 
progenitors express Pdx1 while new islet cells originate from Neurog3+ cells of the 
ductal epithelium (Gu et al., 2002; Kopinke and Murtaugh, 2010; Kopp et al., 2011; Solar 
et al., 2009).  The re-expression of these early progenitor markers within duct-like cells 
after PDL suggests that this injury might cause a recapitulation of embryonic 
developmental mechanisms within the adult duct, providing a potential basis for 
induction of β-cell neogenesis in this model. 
 
Muc1+ exocrine cells do not contribute to new β-cells during injury. 
After establishing the PDL injury model, we wanted to determine whether duct 
cells could act as endocrine precursors in this setting.  To perform lineage tracing of  
  44
 
Figure 4.3. PDL does not cause Muc1+ exocrine cells to undergo neogenesis.  
Recombination was induced in 2-month-old Muc1IC2/+; R26REYFP/+ mice, one month prior 
to PDL and the EYFP lineage label (green) analyzed 7 days after injury.  (A) 
Quantification of EYFP duct labeling in ligated and unligated areas.  Number of mice 
analyzed is indicated in each bar.  Data are represented as mean +/- SEM.   (B-C) While 
Muc1IC2 robustly marks acinar cells (ac) and ducts (du) in the unligated (A) as well as 
epithelial duct-like structures (ep) in the ligated portion (B), the lineage label was never 
detected in insulin-expressing β-cells (red) of the healthy or injured portion (A-B).  (D-I) 
Confocal microscopy of EYFP+ and endocrine cells within ducts (D-F) or small clusters 
(G-I), 7 days post-PDL.  EYFP-labeled cells can be found in close contact with either 
insulin+ cells (D-F, arrowhead) or insulin+ and glucagon+ α-cells (G-I) but EYFP is never 
expressed by endocrine cells. Scale bars: A-B, 100 μm; D-F, 50 μm; G-I, 25 μm.  
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ducts, we utilized our recently generated TM-inducible Muc1IC2 Cre-line (Kopinke and 
Murtaugh, 2010).  Muc1 is expressed by duct and acinar cells but, since acinar cells do 
not contribute to new islets during normal homeostasis and injury (Desai et al., 2007; 
Means et al., 2005; Zhou et al., 2007), we could treat the labeling of acinar cells as 
“background”.  Muc1IC2/+; R26REYFP/+mice, which carry a Cre-dependent EYFP reporter 
allele (Srinivas et al., 2001), received three doses of 10 mg TM 30 days before surgery, 
after which they were chased for an additional 7 days.  This pulse-chase scheme was 
chosen to maximize labeling efficiency of exocrine cells and also to allow for clearance 
of TM from the bloodstream before the injury.   
 We have obtained successful PDLs with a total of 16 tamoxifen-treated 
Muc1IC2/+; R26REYFP/+ mice.  We observed ~11 % EYFP labeling within the cytokeratin-
19 (CK19)-expressing ductal epithelium of the ligated pancreata, and 12% in the 
unligated portion (Fig. 4.3A).  Interestingly, Muc1IC2 consistently labels a 2-4-fold 
greater proportion of acinar cells than ducts in the unligated portions of our PDL 
specimens (Fig. 4.3B).  The fact that the labeling indices of ducts are almost the same 
between unligated and ligated pancreata further suggests that the latter population does 
not derive from the more highly-labeled acinar population.  Although acinar cells can 
convert to a duct-like phenotype in vivo (Blaine et al., 2010), our results suggest that this 
does not occur after PDL, and that acini are simply destroyed in this model.  Surprisingly, 
we did not observe any labeling of β-cells in the 12 Muc1IC2/+; R26REYFP/+ PDL 
specimens analyzed.  In fact, after inspecting ~10,000 β-cells present per ligated 
pancreas, not a single EYFP+ β-cell was found (Fig. 4.3 and data not shown).  Confocal 





Figure 4.4. Neurog3 is expressed within Muc1-derived ductal structures.  Muc1IC2/+; 
R26RLacZ/+; Neurog3eGFP/+ mice received 3x10 mg TM one month prior to ligation, and 
were analyzed for the LacZ  lineage label (red) and EGFP expression (green) 7 days after 
surgery.  (A-F) Two Neurog3-expressing cells are present within a small cluster of 
Muc1-derived cells and carry the lineage label (arrowheads).  This indicates that, despite 
the fact that Neurog3 is expressed within Muc1 lineage-derived ducts, these cells do not 





with EYFP+ cells, they were never labeled (Fig. 4.3D-I).  Thus, our findings suggest that 
if neogenesis does occur after PDL, the source is independent of the exocrine population 
labeled by Muc1IC2.  We cannot, however, exclude the possibility that a Muc1-negative 
duct population might represent a source for neogenesis, although we have previously 
shown that Muc1 is expressed throughout the ductal network (Kopinke and Murtaugh, 
2010). 
 By performing lineage tracing of Muc1+ cells in combination with the 
Neurog3EGFP reporter, we sought to determine whether the Muc1+ population is at least 
capable of inducing Neurog3 expression.  Since this reporter expresses GFP, we utilized 
the R26RLacZ reporter instead of EYFP for lineage tracing of Muc1+ exocrine cells.  We 
used the same pulse-chase strategy as before to induce recombination in Muc1IC2/+; 
R26RLacZP/+; Neurog3EGFP/+ mice one month before PDL (n=6).  The distribution of the 
LacZ lineage label was indistinguishable from the EYFP expression seen before, 
demonstrating the interchangeability of the reporter alleles (data not shown).  
Interestingly, we were able to detect a few examples of Muc1-derived cells expressing 
Neurog3 (Fig. 4.4).  Although these are very rare, our ability to detect them confirms that 
Neurog3 can be expressed by Muc1 lineage-labeled duct cells.  Since we never detected 
the lineage label in islet cells, our finding suggests that Neurog3+ Muc1-derived ducts do 
not adopt a β-cell fate.   
  
Discussion 
 A recent study suggested that new β-cells originate from the ductal compartment 
following PDL, but lacked proof from lineage tracing (Xu et al., 2008).  Our experiments 
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use this approach, the most stringent test for changes in cellular phenotype, to assess the 
differentiation capacity of adult duct and acinar cells in the PDL injury model.  Our 
findings suggest, however, that adult Muc1+ ducts, unlike their counterparts in the 
embryo, have no ability to give rise to new β-cells.   
 Since 2008, nine different TM-inducible CreERT have been described to label, to 
varying degree, the ductal compartment and five of those have been used to perform 
lineage tracing after PDL (see Chapter 5 for a more detailed discussion).  Our findings 
arguing against neogenesis are identical to those obtained with Hnf1bCreER (Solar et al., 
2009), Hes1C2 (Kopinke et al., 2011), Sox9CreER (Kopp et al., 2011) and Sox9IRES-CreERT 
(Furuyama et al., 2011).  Taken together, these studies strongly suggest that new β-cells 
arise after PDL either from pre-existing β-cells, or from a duct subpopulation that 
expresses neither Muc1, Hnf1b, Hes1 nor Sox9 (Inada et al., 2008).   
 If neogenesis is not induced by PDL, what potential role might Neurog3 play in 
this injury model?  It was recently shown that Neurog3 is expressed in mature islets using 
three independent lines of Neurog3 knock-in reporter mice and mRNA/protein-based 
assays.  By inactivating Neurog3 in insulin-expressing β-cells, it was further shown that 
Neurog3 is required for β-cell maturation and maintenance during postnatal expansion 
and homeostasis (Wang et al., 2009).  Neurog3 knockdown using shRNA during PDL 
also inhibits the expansion and proliferation of islet cells normally seen after injury (Xu 
et al., 2008).  These results not only highlight the important role of adult Neurog3 
expression but could also provide an alternative explanation for the shRNA knockdown 
results, which might have disrupted expansion of pre-existing β-cells rather than 
neogenesis.   
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 Additionally, the finding that PDL induces doubling of β-cell mass was recently 
put into question.  Traditionally, total β-cell mass was determined by measuring the area 
occupied by insulin staining within several representative sections, divided by the total 
section area and multiplied by the weight of the pancreas (Solar et al., 2009; Wang et al., 
1995; Xu et al., 2008).  This so-called morphometric measurement of β-cell mass is, 
however, skewed by the total loss of the acinar tissue, which represent ~90% of the 
pancreas, and the concomitant edema (Fig. 4.1C and F).  As an alternative approach, 
Kopp et al. measured whole pancreas insulin content and found that there was no change 
between unligated and ligated pancreata, raising the possibility that the β-cell 
compartment does not expand in response to PDL (Kopp et al., 2011).    
 Generation of new β-cells from endogenous precursors could provide an attractive 
and noninvasive method to treat human diabetes; our work suggests that if such 
precursors exist, they are not located within the ductal compartment.  Our findings not 
only add to the growing body of evidence against β-cell neogenesis but also raise doubts 
on the suitability of the PDL model as a starting point for further investigations aimed to 
increase β-cell mass.  
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ONGOING NOTCH SIGNALING MAINTAINS PHENOTYPIC  
 






 Tissue maintenance during homeostasis or repair from injury is achieved through 
three potential mechanisms.  In the classic stem cell model, both cell turnover and 
pathological cell loss are counterbalanced by continuous influx from dedicated adult stem 
cells.  Another model involves replacement of lost cells by replication of pre-existing, 
fully differentiated cells.  According to a hybrid “facultative stem cell” model, however, 
differentiated cells of one lineage can give rise to another, under specific circumstances 
such as injury (Yanger and Stanger, 2011).  This model remains controversial in most 
tissues, for want of support by lineage tracing and/or evidence for molecular mechanism. 
 The mammalian pancreas experiences very little cell turnover during normal 
homeostasis, and most evidence to date indicates that its cell types are maintained by 
faithful replication of pre-existing cells.  In the adult endocrine pancreas, replication is 
the main mode of generating new insulin-producing β-cells (reviewed in Pan and Wright, 
2011).   Replication also appears to be the mechanism by which acinar cells, belonging to 
the exocrine pancreas, are maintained during adult homeostasis and regeneration (Desai 
et al., 2007; Strobel et al., 2007).  The cell most often proposed as an adult progenitor-
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like cell in the pancreas is the centroacinar cell (CAC).  CACs represent the terminal 
element of the ductal tree and are characterized by their central position within individual 
acinar rosettes (Ekholm et al., 1962).  CACs are considered potential cells-of-origin for 
pancreatic cancer (Maitra and Hruban, 2008; Stanger et al., 2005), have been suggested 
to produce new β-cells following injury (Hayashi et al., 2003; Nagasao et al., 2003), and 
they exhibit progenitor-like behavior following isolation and culture in vitro (Rovira et 
al., 2010).  Whether CACs actually behave as adult progenitor cells in vivo has remained 
controversial, as tools for lineage tracing these cells have been lacking until very 
recently. 
 Another feature of CACs, and to a lesser extent ducts, is that they express Hes1, a 
downstream target of the Notch signaling pathway (Kopinke et al., 2011; Miyamoto et 
al., 2003; Parsons et al., 2009; Stanger et al., 2005).  Activation of this pathway involves 
juxtacrine interactions between ligands of the Delta/Serrate family and receptors of the 
Notch family, which trigger the protease-induced release and nuclear translocation of the 
Notch intracellular domain (NIC).  Nuclear NIC binds the transcription factor 
Su(H)/CSL/RbpJκ (henceforth referred to as RbpJ), and coactivates target genes 
including the Hes/Hey family of transcriptional repressors (Kageyama et al., 2007; 
Kopan and Ilagan, 2009).  Across multiple phyla and tissues, Notch signaling frequently 
acts to maintain “stemness” or to control binary cell fate decisions (Chiba, 2006).  In the 
embryonic pancreas, hyperactivation of Notch inhibits exocrine acinar cell development 
and instead promotes progenitor maintenance (Esni et al., 2004; Hald et al., 2003; 
Murtaugh et al., 2003). 
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 We have recently generated a new tamoxifen-inducible Cre line under the control 
of the Hes1 promoter (Hes1CreERT2, abbreviated Hes1C2), which faithfully marks Hes1+ 
CACs.  By performing lineage tracing, we showed that Hes1-expressing CACs do not 
contribute to new β- or acinar cells during adult homeostasis.  During embryogenesis, 
however, Hes1+ cells represent bipotent exocrine progenitor in which ectopic Notch 
promotes duct specification at the expense of acinar fate (Kopinke et al., 2011).  Thus, 
sustained Notch signaling in Hes1+ CACs might restrain the full differentiation potential 
of these cells.  In the current study, therefore, we aimed to challenge the system by 
disrupting Notch signaling specifically in Hes1-expressing cells, during normal 
homeostasis and after pancreatic ductal ligation (PDL).  To examine further a potential 
role of CACs in acinar cell regeneration, we also performed Hes1 lineage tracing after 
caerulein-induced pancreatitis.  We find that acute loss of RbpJ in adult Hes1+ CACs 
causes their rapid transdifferentiation into acinar but not islet cells, suggesting that loss of 
Notch activity uncovers a facultative acinar progenitor cell phenotype in CACs.  In fact, 
we find also that wild-type Hes1-expressing CACs contribute to regeneration of acinar 
cells following acute pancreatitis.  Our results provide the first evidence of an 




Materials and methods 
 
Mice 
 Hes1C2 (Kopinke et al., 2011), R26REYFP (Srinivas et al., 2001) and RbpJ lox (Han 
et al., 2002) mice have been described previously.  Ptf1aCreERT mice were generated by 
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recombinase-mediated cassette exchange (Burlison et al., 2008), inserting the CreERT 
coding region into the first exon of Ptf1a (full details of this allele will be published 
elsewhere).  RbpJ lox mice, kindly provided by Tasuku Honjo (Kyoto University) and 
Sean Morrison (University of Michigan), were crossed to Hprt-Cre deletor mice (Tang et 
al., 2002) to generate a null (RbpJ Δ) allele.  PCR genotyping for the floxed allele of RbpJ 
was performed as described (Han et al., 2002); for the null allele the following oligos 
were used: wt forward: 5'- TAACTATCTTGGAAGGC TAAAAT-3'; and mutant 
reverse: 5'- GCTTGAGGCTTGATGTTCTGTATTGC-3' (598 bp product). 
 
Animal experiments 
 Tamoxifen (Sigma T-5648) was dissolved in corn oil, and administered by oral 
gavage at doses of 5 mg (Ptf1aCreERT) or 10 mg (Hes1C2) per mouse between 6-8 weeks of 
age.  BrdU (Sigma) was dissolved in drinking water (1 mg/ml) and provided to mice ad 
libitum 3 days prior to and until 7 days after tamoxifen treatment.  Pancreatic duct 
ligations were performed as described (Kopinke et al., 2011).  Acute pancreatitis was 
induced in Hes1C2/+; R26REYFP/+ mice by eight hourly i.p. injections of caerulein 
(Bachem; 0.1 μg/g in saline) per day over 2 days (Jensen et al., 2005).  Control mice 
received the equivalent amount of saline alone.  Serum amylase levels were monitored by 
obtaining blood samples one day before the first injection and 1 hour after the last.  
Amylase levels were measured on a VMax Kinetic microplate reader (Molecular 
Devices) using Infinity serum amylase reagent (Thermo-Fisher).  All animal procedures 
were approved by the Institutional Animal Care and Use Committee of the University of 
Utah. 
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Staining and analysis 
 Immunostaining and analysis were performed as previously described (Kopinke et 
al., 2011; Kopinke and Murtaugh, 2010).  The following primary antibodies were used: 
sheep anti-amylase 1:2500 (BioGenesis), rat anti-BrdU 1:2000 (Abcam), rabbit anti-
cytokeratin-19 1:1500 (Ben Stanger), rat anti-cytokeratin-19 1:50 (Developmental 
Studies Hybridoma Bank), rabbit anti-cleaved Caspase3 1:1000 (Cell Signaling), rat anti-
E-cadherin 1:2000 (Zymed), rabbit anti-GFP 1:4000 (Abcam), goat anti-GFP 1:2500 
(Rockland), guinea pig anti-glucagon 1:2500 (Linco), rabbit anti-glucagon 1:2500 
(Zymed), guinea pig anti-Insulin 1:2000 (Dako), rabbit anti-Ki67 1:150 (Vector labs) and 
rabbit anti-Ptf1a 1:800 (gift from Helena Edlund).  All secondary antibodies (raised in 
donkey) were obtained from Jackson Immunoresearch.  To detect Ki67 and BrdU by 
immunofluorescence, a 15 min DNAse I digestion (700 U/μl, in 40 mM Tris-HCl pH 7.4, 
10 mM NaCl, 6 mM MgCl2, 10 mM CaCl2) was necessary (Ye et al., 2007).  Periodic 
Acid Schiff (PAS) staining was carried out according to the manufacturer's instructions 
(Sigma).  For quantifications, co-immunofluorescence was determined using the Analyze 
Particles function of ImageJ (NIH) and confirmed by eye in Adobe Photoshop.  
Calculations and graphs were generated with Microsoft Excel and R (www.r-project.org).  
P-values were determined by Tukey’s HSD test in R and data are represented as mean +/- 
SEM.  The numbers of mice used for each experiment are indicated in each graph.  
Acinar dissociation was performed as previously described (Kopinke and Murtaugh, 





Hes1-specific deletion of RbpJ in adult intestine and pancreas 
 RbpJ encodes the CSL transcription factor through which Notch activates target 
genes (Kopan and Ilagan, 2009).  To determine a potential role for Notch signaling in 
rare Hes1+ cells of the adult pancreas, we conditionally deleted a floxed RbpJ allele (Han 
et al., 2002) using our tamoxifen (TM)-inducible Hes1CreERT2 line (Hes1C2) (Kopinke et 
al., 2011).  As depicted in Fig. 6.1A, our breeding scheme yielded both Hes1C2/+; 
R26REYFP/+; RbpJlox/+ mice, which are heterozygous for the floxed allele (henceforth 
referred to as Hes1-lox), and Hes1C2/+; R26REYFP/+; RbpJ lox/Δ animals, which carry a null 
(Δ) and a floxed allele of RbpJ (Hes1-cKO).  All genotypes also included the R26REYFP 
reporter allele (Srinivas et al., 2001), which allowed us to follow the fate of recombined 
Hes1-lox and Hes1-cKO cells (see below).  Hes1-cKO mice were born at normal 
Mendelian ratios and were phenotypically indistinguishable from wild-type or Hes1-lox 
animals before TM administration.  It should be noted, however, that Hes1-cKO animals 
are compound heterozygotes for two major Notch components, Hes1 and RbpJ.  To 
exclude any defects caused by potential compound haploinsufficiency, we generated 
additional control mice that carry the null rather than the floxed allele of RbpJ (Hes1C2/+; 
R26REYFP/+; RbpJ Δ/+; referred to as Hes1-het).  In all experiments, unless otherwise 
indicated, 10 mg TM was administered to 6-8 week old adult mice, which were chased 
for 7 days (short term) or 2 months (long term) (Fig. 6.1B).   
 To confirm the successful deletion of RbpJ with our pulse-chase strategy, we first 
analyzed the small intestine of Hes1-lox and Hes1-cKO mice at 7 days post-TM.  It was 














Figure 6.1. Hes1-specific deletion of RbpJ in the pancreas and intestine. (A) Breeding 
strategy to generate a Hes1-specific knockout of RbpJ.   Animals heterozygous for a null 
(Δ) and a floxed (lox) allele of RbpJ (RbpJ lox/Δ) are abbreviated Hes1-cKO, while RbpJ 
lox/+ mice serve as controls (Hes1-lox).  In some experiments, RbpJ Δ/+ mice were included 
as an additional control (Hes1-het).  All mice also carry a R26REYFP reporter allele, 
allowing for lineage tracing of recombined cells.   (B) Pulse-chase strategy.  
Recombination was induced by TM administration in 6-8 week old adults and animals 
were chased for 7 days (short term) or 2 months (long term) before analyzing.  (C-F) 
Comparison of PAS-stained intestine (C-D) and H&E-stained pancreata (E-F) between 
Hes1-lox (C and E) and Hes1-cKO (D and F) mice after a 7 day chase.  Intestinal KO of 
RbpJ (C) leads to widespread transformation of the gut epithelium into PAS+ goblet cells.  
In contrast, no morphological differences were detected between Hes1-lox (E) and Hes1-
cKO (F) pancreata.   (G) PCR strategy to detect successful recombination of the floxed 
allele of RbpJ.  While the deletion band of RbpJ can only be detected in tail DNA from 
RbpJlox/Δ (1) but not wild-type (RbpJ+/+, 2) or RbpJlox/+ (3) mice prior to TM, the band is 
visible post-TM-induced recombination using DNA from the pancreas (4) or duodenum 
(5) of the same RbpJlox/+ mouse (3).  Abbreviations: ac, acinar; is, islet; du, duct.  Scale 




conversion of the intestinal epithelium into goblet cells (Kim and Shivdasani, 2011; 
Riccio et al., 2008; van Es et al., 2005).  Hes1C2 labels intestinal stem cells (Kopinke et 
al., 2011), and deletion of RbpJ in the Hes1+ stem cell compartment caused robust 
transformation of the gut epithelium into PAS+ positive goblet cells (Fig. 6.1C-D).  Hes1-
specific deletion of RbpJ in the pancreas, however, did not result in any obvious 
morphological differences between control and Hes1-cKO mice at 7 days post-TM (Fig. 
6.1C-D).  To confirm successful recombination in the pancreas, we performed PCR to 
detect the deletion (Δ) allele of RbpJ (Fig. 6.1G).  As expected, the deletion-specific 
product could only be detected in the pancreas and intestine of Hes1-lox (lox/+) mice 
after TM-induced recombination of the floxed allele. 
 
Deletion of RbpJ in Hes1-expressing duct cells blocks their expansion 
 We previously showed that Hes1C2 marks a subset of cells within large ducts of 
the adult pancreas, as well as CACs (Kopinke et al., 2011).  Importantly, the main duct 
cells labeled by Hes1C2 appear to expand preferentially compared to unlabeled cells, 
suggesting that Hes1 marks a proliferating subpopulation within the ducts.  As a recent 
study suggested that Jagged1-Notch signaling was mitogenic for ducts (Golson et al., 
2009), we analyzed RbpJ knockouts for any defects of the ductal tree.  Since all mice also 
carry the Cre-dependent R26REYFP reporter allele, TM-induced recombination will result 
in simultaneous deletion of the floxed allele of RbpJ and activation of EYFP expression.  
This should allow us to directly and quantitatively compare Hes1-lox to Hes1-cKO cells 
by virtue of EYFP expression, and determine whether there was a change in the EYFP 








Figure 6.2.  Deletion of RbpJ inhibits expansion of Hes1C2-labeled ducts.  (A-D) 
Adult Hes1-lox and Hes1-cKO mice were treated with tamoxifen and stained for EYFP 
(green) and the duct marker CK19 (red) after 7 days (A-B) and 2 months (C-D).  While 
there is no difference in the fraction of EYFP-labeled duct cells (arrowheads) between 7 
day chased Hes1-lox and Hes1-cKO animals (A-B), an increase is detected between 7 
days and 2 month in Hes1-lox mice (C), which is inhibited in Hes1-cKO animals (D).    
(E) Quantification of duct EYFP labeling index.  (*P<0.05).  (F-G) EYFP (green) and 
BrdU (red) labeling of CK19+ CACs (white), 7 days post-TM and following a 10 day 
BrdU pulse.  CACs expressing EYFP only (open arrowheads) or positive for both EYFP 
and BrdU (closed arrowheads) can be found in Hes1-lox mice.  In contrast, Hes1-cKO 
animals have fewer EYFP+ CACs, and most of the BrdU+ CACs are EYFP-negative 
(yellow arrowhead).  (H) Quantifications of EYFP and BrdU labeling indices of 
intercalated ducts and CACs reveal a 2-fold decrease in EYFP labeling in Hes1-cKO 
mice, as well as a 2-fold reduction in the number of cycling (BrdU+) EYFP-labeled 
intercalated ducts and CACs (* P<0.05).  (I) Quantifications of EYFP and BrdU labeling 
indices of intra- and interlobular ducts indicate no differences between Hes1-lox and 
Hes1-cKO mice (P=0.75).  Data are represented as mean +/- SEM.  Numbers in bars (E, 















 As previously (Kopinke et al., 2011), we could detect an increase in the fraction 
of labeled CK19+ duct cells between 7 days and 2 months in Hes1-lox mice.  By 
comparison, the labeling index of Hes1-cKO ducts remains the same regardless of the 
chase period (Fig. 6.2A-E) suggesting that the expansion of Hes1+ ducts requires Notch 
activity.  The ductal tree can be divided into large (intra- and interlobular) and small 
ducts (intercalated, terminal ducts and CACs) (Kopinke and Murtaugh, 2010).  Since 
Hes1+ cells are distributed throughout the ductal network, it is possible that loss of RbpJ 
results in different outcomes at different positions within the network.  Therefore, Hes1-
lox and Hes1-cKO ductal trees were analyzed for the contribution of EYFP+ cells 
specifically to large and small ducts 7 days post-TM.  Since terminal ducts and CACs are 
phenotypically similar and may represent one, two or more specific cell types (Ekholm et 
al., 1962; Rovira et al., 2010), we will henceforth refer to them collectively as CACs.  
Interestingly, the fraction of EYFP+ intra- and interlobular ducts and their ability to 
proliferate did not change after a short-term loss of RbpJ (Fig. 6.2I).  In contrast, we 
found an approximately 2-fold reduction in the fraction of EYFP+ intercalated ducts and 
CACs, 7 days post-TM treatment.  This decrease in labeled CAC was concomitant with 
reduced proliferation of these cells, evidenced by BrdU uptake and Ki67 staining (Fig. 
6.2F-H and data not shown).  Staining for cleaved Caspase-3 after a 2- or 7-day chase did 
not reveal increased apoptosis of RbpJ-deficient CACs (n=2 per genotype and time point, 
data not shown).  Together, our data suggest that Notch signaling is required for the 
gradual expansion of Hes1+ cells within large ducts, while the maintenance of Hes1+ cells 
in intercalated ducts and CACs is acutely Notch-dependent.  The apparent lack of cell 
death in the latter population raises the possibility that these cells change their 
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Figure 6.3.  Loss of RbpJ in Hes1+ cells results in dramatic increase of labeled acinar 
cells.  (A-D) Adult Hes1-lox and Hes1-cKO pancreata were analyzed for co-expression 
of EYFP (green) with the acinar marker amylase (red), 7 days (A-B) and 2 months (C-D) 
post-TM.  The fraction of EYFP+ acini in Hes1-lox animals remains constant between 7 
days (A) and 2 month (C).  In contrast, a drastic increase in labeled acinar cells is seen 
both 7 days (B) and 2 month (D) after loss of RbpJ.  (E) Quantification of the fraction of 
EYFP+ acinar cells after a 7 day and 2 month chase.   The fraction of EYFP-expressing 
acinar cells increases 3.5-fold at the 7 day and 2 month chase time points in Hes1-cKO 
pancreata (* P<0.005).  (G-H) BrdU/EYFP labeling at 7 days post-TM.  Only a few 
EYFP-expressing acinar cells are also positive for BrdU (white, arrowheads) in Hes1-lox 
mice (G).  In contrast, Hes1-cKO animals display an increase in cycling EYFP+ acinar 
cells (H).  (I) Quantification of EYFP/BrdU labeling of acinar cells reveals a 2-fold 
increase in Hes1-cKO mice (* P<0.005).  Data are represented as mean +/- SEM.  
Numbers in bars (E, I) indicated mice analyzed per group.  Scale bars: A-D, 100 μm; G-
H, 50 μm.   
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differentiated fate and, therefore, carry the EYFP label into a different lineage. 
 
Dramatic increase of Hes1+ acinar cells after loss of RbpJ 
 While analyzing the EYFP distribution within ducts, we were surprised to find a 
greater fraction of labeled acinar cells in Hes1-cKO pancreata compared to Hes1-lox 
(Fig. 6.3A-D).  This effect was quite rapid: within 7 days of tamoxifen administration, 
Hes1-cKO pancreata exhibited an approximately 3.5-fold increase in labeled acinar cells, 
which did not increase further after 2 months (Fig. 6.3E).  This increase in labeling 
frequency was not due to compound haploinsufficiency for RbpJ and Hes1, as the 
labeling index of Hes1-het mice was indistinguishable from Hes1-lox.  Notch signaling 
has previously been suggested to inhibit acinar cell proliferation (Siveke et al., 2008).  To 
determine whether the expanded acinar labeling in Hes1-cKO could be attributed entirely 
to division of rare Hes1C2-labeled acinar cells (Kopinke et al., 2011), we continuously 
supplied Hes1-lox and Hes1-cKO mice with BrdU in the drinking water from 3 days 
prior to TM through harvesting, in order to capture all cycling cells during our chase 
period (Teta et al., 2007).  After a 7 day chase, ~2% of EYFP+ acinar cells are positive 
for BrdU in Hes1-lox mice, compared to ~4% in Hes1-cKO mice (Fig. 6.3G-I).  Because 
the initial fraction of BrdU+ acinar cells is very low, and increases only 2-fold in Hes1-
cKO mice, accelerated proliferation and expansion of Hes1+ acinar cells upon loss of 
RbpJ seems unlikely to explain fully the dramatic increase in EYFP+ acinar cells. 
 To test more directly the effects of RbpJ on acinar cell proliferation, we sought to 






Figure 6.4.  No increased proliferation after acinar-specific loss of RbpJ.  (A) To 
determine whether Notch generally represses expansion of acinar cells, RbpJ was deleted 
using an inducible Ptf1aCreERT Cre driver, which induces mosaic recombination in acinar 
cells (Ptf1a-lineage, green) but not ducts or CACs.  (B) Short term lineage tracing of 
Hes1+ cells (green) demonstrates that all EYFP+ acinar cells (arrowheads) also express 
Ptf1a (white).  (C-D) At 7 days post-TM, no difference is detected, between Ptf1a-lox 
and Ptf1a-cKO, in EYFP labeling (green) of amylase+ acinar cells (red).  (E) There is no 
change in the fraction of EYFP+ acinar cells after a 7 day chase (P=0.52).  (F) 
Quantification of BrdU labeling analysis 7 days post-TM.  The EYFP/BrdU labeling 
index of acinar cells remains the same between control (lox and het) and Ptf1a1-KO 
animals (P=0.81).  Data are represented as mean +/- SEM.  Numbers in bars (E-F) 
indicate mice analyzed per group.  Scale bars: B, 50 μm; C-D, 100 μm.   
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Cre line under the control of the acinar-specific transcription factor Ptf1a (Ptf1aCreERT) 
(Fig. 6.4A).  Immunostaining confirmed that Ptf1a was expressed by all acinar cells, 
including the subpopulation labeled by Hes1C2 (Fig 6.4B).  Similar to our Hes1C2 
breeding scheme (Fig. 6.1A), we generated mice containing floxed and wild-type RbpJ 
alleles (Ptf1a-lox, Ptf1aCreERT/+; R26REYFP/+; RbpJ lox/+), or a floxed and null (Ptf1a-cKO, 
Ptf1aCreERT/+; R26REYFP/+; RbpJ lox/Δ).  As before, all mice also carried one allele of the 
R26REYFP reporter for lineage tracing (Fig. 6.4A).  We found no difference between Ptf1a-
lox and Ptf1a-cKO in the EYFP labeling of acinar cells at 7 days post-TM (Fig. 6.4C-E).  
Using the same BrdU labeling scheme as above, we also detected no change in the 
fraction of EYFP-expressing, BrdU+ acinar cells between genotypes (Fig. 6.4F).  These 
results argue against a role for Notch in regulating proliferation/expansion of mature 
acinar cells, and raise the possibility of a Notch-regulated influx to the acinar 
compartment from another cell type. 
 
Loss of RbpJ causes rapid transdifferentiation of CAC into acinar cells 
 The disappearance of EYFP+ intercalated ducts and CACs (Fig. 6.2), and our 
finding that Notch does not inhibit acinar proliferation (Fig. 6.4), prompted us to 
investigate whether the observed increase of EYFP+ acinar cells in Hes1-cKO mice was 
due to transdifferentiation of CACs (Fig. 6.5A).  To analyze individual acinar units, and 
avoid missing small CACs due to sectioning artifacts, we performed enzymatic digestion 
to dissociate the pancreas into clusters containing only acinar cells and CACs (referred to 
as acinar preps; Fig. 6.5B) (Kopinke and Murtaugh, 2010; Kurup and Bhonde, 2002).  






Figure 6.5.  Transdifferentiation of Hes1+ CAC into acinar cells upon RbpJ 
knockout.  (A) We hypothesize that the increase in acinar labeling after loss of RbpJ is 
due to CACs adopting an acinar fate.  (B) Dissociation of whole pancreata generates 
small cell clusters containing amylase+ acinar cells (green) and CK19+ CACs (red).  (C) 
Clusters from Hes1 lineage traced (green) pancreata were divided into two major 
categories, based on the presence (class 1) or absence (class 2) of labeled CACs as 
indicated.  Class 1 clusters contain only EYFP+ CACs (1a) or EYFP+ CACs and acini 
(1b) and class 2 clusters contain EYFP+ acini with unlabeled CACs (2a) or EYFP+ acini 
with no CACs (2b).  Inserts represent schematic representations of cluster types.  (G-H)  
Immunofluorescence for EYFP (green) and CK19 (red) of clusters from dissociated 
pancreata of Hes1-lox and Hes1-cKO animals at 7 days post-TM.  Only clusters 
containing 3 or more acinar cells were scored (circle).  Most of the Hes1-lox clusters 
contain labeled CAC (arrowhead) and belong to class 1, while CACs are either unlabeled 
or absent altogether in Hes1-cKO clusters (classes 2a and 2b).  (I) Scoring of cluster 
types from two independent experiments demonstrates a shift in the proportion of clusters 
from type 1a and 1b to 2a and 2b between Hes1-lox and Hes1-cKO mice (* P<0.0005).  
Note that the denominator represents the number of total clusters present per field, 
including EYFP-negative ones.  (J-K) Immunofluorescence for amylase (green) and 
CK19 (red) of cell clusters from Hes1-lox (J) and Hes1-cKO (K) pancreata 48 hrs after 
TM administration.  In Hes1-lox mice (J), CK19 and amylase expression are restricted to 
CAC and acinar cells, respectively.  After TM induction (K), some amylase+ acinar cells 
are also positive for CK19 (dotted outline).  Co-expression of duct and acinar markers is 
seen only in EYFP+ cells (right).  Right, single-channel amylase, CK19, EYFP and DAPI 
staining as indicated.  Data are represented as mean +/- SEM.  Numbers in bars (I) 














major categories based on the presence (class 1) or absence (class 2) of EYFP-labeled 
CACs.  In class 1, we scored clusters in which only CACs were labeled (1a) or in which 
both CACs and acini were labeled (1b).  In class 2, we scored clusters containing labeled 
acini with unlabeled CACs (2a) or labeled acini with no CACs at all (2b).  If CACs were 
converting to acinar cells after RbpJ deletion, we would expect a decrease in class 1 
clusters and an increase in class 2.  Indeed, we found that the majority of Hes1-lox 
clusters were of class 1, while class 2 predominated in Hes1-cKO (Fig. 6.5G-H).  
Quantification revealed a 3.5-fold reduction, in Hes1-cKO mice, of the class 1 cluster 
frequency, and a concomitant increase (2.5-fold) of class 2 clusters (Fig. 6.5I), suggesting 
that CACs convert to acinar cells after loss of RbpJ. 
 If CACs are indeed capable of adopting an acinar fate, we should detect 
transitional cells expressing both duct and acinar markers.  By analyzing acinar preps 
from a 48 hr chase, we were able to detect EYFP+ cells co-expressing the duct marker 
CK19 and the mature acinar marker amylase in Hes1-cKO mice specifically (Fig. 6.5J-
K).  At later chase time points, we no longer observed EYFP-labeled double-positive 
cells.  Thus, loss of RbpJ in CACs causes a rapid and complete transition to an acinar 
fate.  These results suggest that Hes1+ CACs can act as facultative acinar progenitors, and 
that their differentiation status is controlled by Notch activity. 
 
Lack of exocrine-to-endocrine conversion after RbpJ deletion 
 Wild-type Hes1+ cells, including CACs, do not contribute to new β-cells during 
normal homeostasis or after PDL (Kopinke et al., 2011).  Nonetheless, the results above 








Figure 6.6.  Loss of RbpJ does not cause exocrine to endocrine conversion.  (A-D) 
Adult Hes1-lox and Hes1-cKO pancreata were analyzed for expression of EYFP (green) 
by glucagon+ α-cells (red) and insulin+ β-cells (white), at 2 months post-TM.  While 
fewer α-cells are marked by EYFP (arrowhead) in Hes1-cKO (C) compared to Hes1-lox 
animals (A), no β-cells are labeled either in large islets (A and C) or in small clusters (B 
and D), regardless of genotype.  (E) Quantification of EYFP/glucagon labeling 7 days 
and 2 month post-TM.  The expansion of EYFP-labeled α-cells between 7 days and 2 
month, seen in Hes1-lox animals (* P<0.05), is blocked in Hes1-cKO mice.  (F) Adult 
Hes1-lox and Hes1-cKO animals were subjected to PDL, received TM three days after 
and were chased for 7 additional days before analyzing.  (G-L) Comparison of unligated 
(G and J) and ligated areas (H-I and K-L) from Hes1-lox (G-I) and Hes1-cKO pancreata 
(J-L) 10 days after PDL.  Hes1-lox (G) and Hes1-cKO (J) EYFP-expressing cells (green) 
can be found within ducts (du, closed arrowheads) and acinar cells (ac) in the unligated 
pancreas but not in β-cells (white) of islets (is).  In ligated areas of both genotypes, 
EYFP+ cells are present only in ducts and epithelial clusters (ep, marked by E-cadherin in 
blue) (H and K).  Individual unlabeled β-cells (red, open arrowheads) can be found in 
proximity to EYFP+ ducts in Hes1-lox (I) and Hes1-cKO mice (L).  Data are represented 
as mean +/- SEM.  Numbers in bars (E) indicate mice analyzed per group.  Scale bars: A-












excluded.  We therefore wanted to determine whether loss of RPB-J in Hes1+ cells could 
allow them to adopt a β-cell fate as was shown in vitro (Rovira et al., 2010).  We first 
looked for a possible contribution to new β-cells during normal homeostasis, and could 
not find a single insulin+ β-cell labeled by EYFP after a 7-day or 2-month chase in Hes1-
cKO mice (Fig. 6.6A-D).  We did find, however, that the progressive expansion of 
EYFP-labeled α-cells (glucagon+), observed in Hes1-lox and wild-type mice (Kopinke et 
al., 2011), was abolished in Hes1-cKO animals (Fig. 6.6A-E).  Although these cells are a 
minute fraction of the total α-cell population, our results suggest that their expansion, like 
that of Hes1+ duct cells, is Notch-dependent. 
 It has been suggested that duct cells can generate new β-cells under various injury 
settings, including pancreatic duct ligation (PDL) (Murtaugh and Kopinke, 2008; Pan and 
Wright, 2011).  In this model, re-expression of the pro-endocrine transcription factor 
Neurog3 can be observed within ductal structures (Xu et al., 2008).  Since Hes1 represses 
the Neurog3 promoter (Lee et al., 2001), we wanted to determine whether loss of RbpJ in 
Hes1-expressing duct cells would enhance Neurog3-dependent β-cell neogenesis to the 
point that it could be directly observed by lineage tracing.  Hes1-lox and Hes1-cKO mice 
received TM 3 days after duct ligation and were chased for 7 additional days.  In the 
ligated areas of Hes1-lox and Hes1-cKO mice around 15% and 22% of CK19+ ducts were 
labeled, respectively (Fig. 6.6G-L).  After scoring several thousand insulin+ β-cells and 
EYFP+ ducts, however, we did not detect any β-cells expressing EYFP (Table S1).  Thus, 
Hes1+ duct cells, even after losing RbpJ, are not capable of giving rise to new β-cells. 
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CAC contribute to new acinar cells following acute pancreatitis 
 Our finding that RbpJ deletion causes CAC-to-acinar transdifferentiation 
prompted us to determine whether wild-type CACs can also contribute to acinar cells 
under physiological conditions.  Since no influx from CACs to acini was detected during 
steady state conditions (Kopinke et al., 2011; Kopp et al., 2011), we utilized an exocrine 
regeneration model in which acute pancreatitis is induced by supraphysiological levels of 
the acinar secretagogue caerulein (Jensen et al., 2005).  This treatment paradigm causes 
widespread acinar cell death within 2-3 days of treatment, followed by complete recovery 
of acinar mass 7-14 days later (Jensen et al., 2005).  The extensive acinar turnover in this 
model provided a system to investigate whether wild-type Hes1+ CACs could contribute 
to newly-generated acinar cells.  To this end, we induced acute pancreatitis in Hes1C2/+; 
R26REYFP/+ mice and determined the fate of wild-type, Hes1C2-labeled cells. 
 Measurement of serum amylase confirmed robust injury induced by caerulein 
treatment.  At 14 days after the last caerulein injection, we found no gross or histological 
difference between saline- and caerulein-treated mice, demonstrating that the pancreas of 
treated animals had fully regenerated (Fig. 6.7A-B and data not shown).  Next, we 
examined the distribution of EYFP-expressing cells at the 14-day timepoint.  Saline-
treated Hes1C2/+; R26REYFP/+ mice exhibited a homogenous low frequency of EYFP-
labeled acinar cells, similar to our previous findings (Kopinke et al., 2011).  In contrast, 
caerulein treatment caused an apparent focal increase in EYFP-labeled acinar cells (Fig. 
6.7A-B), indicating either that Hes1-derived acinar cells expanded, or that EYFP-marked 
CACs contributed to new acinar cells.  The increased heterogeneity of labeling, following 
caerulein treatment, suggested that injury had affected some regions of the organ more 
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Figure 6.7.  Contribution of Hes1+ CAC to new acinar cells following pancreatitis.  
(A-D) Sections (A-B) and dissociated acinar clusters (C-D) from adult Hes1CF/+; 
R26REYFP/+ pancreata were analyzed for EYFP (green) and CK19 (red) expression 14 
days after caerulein-induced acute pancreatitis.  In contrast to saline treated mice (A and 
C), caerulein treatment (B and D) causes an increase in the fraction of Hes1C2-labeled 
acinar cells as well as marked CACs (arrowheads).  (E) Quantifying the EYFP labeling 
index of acinar cells at 14 days post-caerulein reveals an increase in caerulein-treated 
mice (* P<0.05).  (F) Scoring the fraction of labeled CK19+ cells indicates a slight 
increase in EYFP+ CAC after regeneration (* P<0.05).  (G) Model: Hes1+ CACs are 
maintained by Notch signaling and can generate new acinar cells during regeneration.  
Data are represented as mean +/- SEM.  Numbers in bars (C, D) indicate mice analyzed 
per group.  Scale bar: 50 μm.    
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than others, which could be over- or under-counted in sections.  Therefore, we utilized 
our acinar prep technique for quantifications, allowing randomization of acinar clusters 
regardless of regional variation.  The fraction of labeled acinar cells (Fig. 6.7C, E) and 
CACs (Fig. 6.7C, F) in saline-treated animals was similar to our previous data (Kopinke 
et al., 2011).  In caerulein-treated mice, however, we observed an increase in the fraction 
of EYFP+ acinar cells (Fig. 6.7D-E) as well as CACs (Fig. 6.7F), suggesting that the 
Hes1-expressing CACs expand and give rise to new acinar cells following pancreatitis.  
Together with our RbpJ deletion experiments, these results suggest that Hes1+ CACs 
represent facultative, acinar-restricted progenitor cells in the adult pancreas (Fig. 6.7G).   
  
Discussion 
 The mammalian pancreas is a generally static organ, and many studies support 
replication as the major mode of postnatal expansion, adult homeostasis and regeneration 
(Desai et al., 2007; Dor et al., 2004; Kopinke and Murtaugh, 2010; Kopp et al., 2011; 
Solar et al., 2009; Strobel et al., 2007; Teta et al., 2007).  Nonetheless, adult cell fates can 
be reprogrammed by the ectopic activation of developmental regulatory factors 
(Collombat et al., 2009; De La O et al., 2008; Zhou et al., 2008).  While such gain-of-
function experiments reveal the potential of adult cells to change fates, they do not 
address the mechanisms by which cells normally maintain phenotypic fidelity.  Here, we 
provide the first evidence that an endogenous signaling pathway acts to prevent cell type 
interconversion in the adult pancreas.  Centroacinar cells can be distinguished from other 
cells of the ductal network by their high level of Notch pathway activity (Kopinke et al., 
2011; Miyamoto et al., 2003; Parsons et al., 2009; Stanger et al., 2005), and we find that 
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this activity is required constitutively to prevent their differentiation into acinar cells.  
Although wild-type CACs are inhibited from differentiating into acinar cells in the 
resting pancreas, our studies further suggest that they can contribute to regenerating 
acinar cells after acute pancreatitis.  In this respect, CACs behave as facultative stem cells 
of the exocrine pancreas. 
 Based on lineage tracing of pre-existing acinar cells, two previous studies had 
argued against a major contribution of nonacinar cells to the acinar compartment 
following pancreatitis (Desai et al., 2007; Strobel et al., 2007).  These studies could not 
exclude a small contribution from nonacinar cells, however, particularly since they did 
not directly label CACs.  In fact, it has been shown that CAC proliferate rapidly shortly 
after the acute injury phase of caerulein-induced pancreatitis (Elsasser et al., 1986; 
Gasslander et al., 1992; Rovira et al., 2010), and radionucleotide uptake studies have 
suggested that CACs might migrate into other pancreatic cell compartments during the 
regeneration phase (Gasslander et al., 1992).  We find that regeneration induces both an 
expansion of Hes1C2-labeled cells within the CAC compartment, and contribution of 
these cells to differentiated acini.  The latter phenomenon accounts for only a small 
fraction of regenerated acinar mass, however, which could have been missed in prior 
studies (Desai et al., 2007; Strobel et al., 2007).  It will be interesting to determine if 
regeneration from more extreme acinar injury evokes a stronger contribution from CACs, 
as predicted by studies of facultative stem cells in the liver (Yanger and Stanger, 2011). 
 The expansion of Hes1+ CACs during regeneration may reflect a mitogenic role 
for the Notch signaling pathway, which is upregulated during pancreatitis (Jensen et al., 
2005).  We have previously found that Hes1+ cells within the main ducts preferentially 
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expand over time (Kopinke et al., 2011), and we show here that this expansion requires 
RbpJ.  These findings converge with a previous study in which loss of Jagged1, a Notch 
ligand, was shown to cause hypoplastic and malformed ducts (Golson et al., 2009).  
Although loss of RbpJ inhibits the progressive expansion of EYFP+ cells within large 
ducts, it does not have any detectable short-term effect on their proliferation.  Therefore, 
we propose that the direct requirement for RbpJ is manifested in CACs, where Notch 
signaling sustains a pool of cells that transition into the ductal tree as it gradually expands 
during postnatal organ growth.  Rapid CAC-to-acinar differentiation after loss of RbpJ 
depletes this pool, preventing further contribution to large ducts. 
 Are Hes1-expressing CACs unique, or do they share properties with other ductal 
cells?  In analyzing conditional RbpJ knockouts, we have not observed ectopic, EYFP-
labeled acinar cells within large ducts, suggesting that cells in these structures are 
incapable of changing fate even after removal of Notch activity.  Furthermore, CACs 
were recently shown to have a unique capacity for multilineage differentiation in cell 
culture, although the cells isolated in that study appeared to be Hes1-negative (Rovira et 
al., 2010).  With respect to in vivo differentiation potential, two other genes expressed by 
ducts and CACs, Hnf1b and Sox9, have been used to generate tamoxifen-inducible Cre 
lines.  Lineage tracing with a Hnf1b-CreERT2 BAC transgene demonstrated that ducts 
and CACs did not contribute to other cell types during homeostasis or following duct 
ligation (Solar et al., 2009).  Similar results were obtained with a Sox9-specific BAC 
transgene (Sox9-CreERT2), indicating that postnatal ducts and CACs do not contribute to 
endocrine or acinar cells (Kopp et al., 2011).  Directly conflicting this finding, however, 
studies using another Sox9 lineage tracing allele (Sox9IRES-CreERT2) showed that the 
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majority of mature acinar cells were repopulated from Sox9-expressing ducts or CACs 
within 4 months (Furuyama et al., 2011).  This report is difficult to reconcile with the 
“pulse-chase” acinar cell labeling experiments described above, which concluded that 
long-term maintenance of acinar cells was based on replication of pre-existing ones 
(Desai et al., 2007; Strobel et al., 2007).  Pending resolution of the Sox9 lineage, the 
weight of the published evidence would suggest that neither ducts nor CACs behave as 
endocrine or exocrine stem cells in vivo, while our findings here suggest that Hes1+ 
CACs represent a facultative progenitor population specific to acinar cells (Fig. 6.7G). 
 Previous studies of Hes1 expression during embryonic pancreas development 
indicated a progressive restriction to cells at the border between acini and ducts (Esni et 
al., 2004), which our lineage tracing experiments identified as an exocrine-specific 
progenitor population in which Notch promotes duct differentiation at the expense of 
acinar (Kopinke et al., 2011).  The experiments reported here suggest that these 
progenitors persist into adulthood, within an anatomical niche ideally suited for 
bipotential lineage contribution.  Located at the termini of the ductal tree, self-renewing 
CACs can transit into the central ductal network and contribute to its overall expansion.  
At the same time, sustained Notch signaling ensures that these cells are available for 
replacement of acinar cells lost to injury.  Notch activity is required for the exocrine 
pancreas to regenerate from pancreatitis (Siveke et al., 2008), and our studies highlight 
the unique contribution of Notch-regulated cell fate determination to the maintenance of 
this organ.  In addition, our findings raise the question of whether other pathways 
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 Loss of insulin-producing β-cells results in type 1 diabetes, which can be 
counterbalanced through the transplantation of new β-cells.  At the onset of my studies, it 
was unknown whether the pancreas contains an endogenous stem/progenitor cell 
population or a differentiated cell type that has the potential of giving rise to new β-cells 
in vivo (neogenesis).  This thesis addressed the following questions:  (1) What is the 
origin of the new β-cells that arise in large numbers shortly after birth?  (2) Is there any 
contribution to new islets from the exocrine tissue (duct and acinar cells) during adult 
homeostasis or regeneration?  (3) Do Hes1-expressing cells constitute multipotent 
progenitors throughout pancreatic organogenesis?  (4) Do the rare Hes1+ cells in the 
mature pancreas represent adult progenitors similar to their embryonic counterparts?   
 The first part of this thesis focused on the embryonic origin of β-cells, through 
genetic lineage tracing with a novel Muc1CreERT2 allele that is expressed specifically in 
exocrine acinar and ductal cells.  During embryogenesis, we could show that Muc1+ 
ducts can differentiate into β-cells and other islets.  Following birth, however, we found 
that Muc1+ cells completely fail to contribute to new islet β-cells.  Thus, our work proves 






Figure 7.1.  Model.  Between E9.5 and E11.5, Hes1+ and Muc1+ cells are multipotent 
and give rise to islet cells through Neurog3-expressing intermediates.  Starting at E13.5 
until birth, endocrine cells arise from Muc1+ ducts, which have downregulated Notch 
activity.  Hes1+ cells at E13.5 represent bipotent exocrine progenitors in which Notch 
inhibits acinar fate.  After birth and in the adult, neogenesis from Muc1+ and Hes1+ ducts 
ceases and islet cells are maintained by proliferation of differentiated cells.  Hes1 
expression persists in Notch-sensitive centroacinar cells, which act as facultative 
exocrine-specific progenitor cells capable of differentiating into duct (during 





expansion and homeostasis of adult islets occurs independent of contribution from ducts 
or acini (Chapter 3 and Fig. 7.1). 
 The second part investigated the possibility of ductal-to-islet differentiation 
during pancreatic ductal ligation (PDL) injury.  This injury was shown to induce doubling 
of β-cell mass possibly caused by influx of new islet cells from ducts (Xu et al., 2008).   
Therefore, we performed lineage tracing during the regeneration process to elucidate 
whether new islet cells can arise from Muc1+ ducts or acini.  In fact, although we could 
detect robust labeling of duct-like cells, often in very close association with insulin+ cells, 
we failed to detect a single Muc1-derived β-cell after PDL.  Our findings, therefore, argue 
against a major role for adult neogenesis even in the context of injury and regeneration 
(Chapter 4 and Fig. 7.1). 
 As duct cells have been proposed as a potential source for β-cell neogenesis, 
several duct-specific Cre lines have been developed since 2008 (Table 7.1). Three of 
these new Cre-drivers, Hnf1bCreER (Solar et al., 2009),  Sox9CreER (Kopp et al., 2011) 
and Sox9IRES-CreERT2 (Furuyama et al., 2011), have been used to perform lineage tracing 
after PDL.  None of these studies, however, found signs of ducts giving rise to new β-
cells.  This raises the question whether neogenesis actually occurs after PDL.  So far, 
three lines of evidence suggest neogenesis in this injury model: (i) β-cell mass undergoes 
doubling, (ii) Neurog3 is re-expressed and Neurog3-derived cells give rise to islets, and 
(iii) silencing of Neurog3 function prevents β-cell expansion (Xu et al., 2008).   
 The notion that β-cells double in mass after PDL, however, was recently put into 
question (Kopp et al., 2011).  Total β-cell mass was previously determined using 





Table 7.1. Novel duct Cre-lines 
 





























Hnf1bCreER BAC x x x no  (Solar et al., 2009) 
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based on determining total endocrine area divided by the total area (including islets, ducts 
and acini), measured over several representative sections, and multiplying by pancreatic 
weight.  It does, however, not take into account the fact that the acinar tissue, which 
makes up the majority of pancreatic cells, is completely lost.  Thus, the denominator for 
the ligated portion is automatically much smaller, resulting in an artificial increase of 
total endocrine area.  Using a different approach, Kopp et al. measured whole pancreas 
insulin content using ELISA and showed that total β-cell mass did not increase after PDL 
(Kopp et al., 2011).  Thus, it is questionable whether β-cell mass really increases after 
PDL and, if it does, whether it actually doubles.   
 It was also suggested that PDL-induced neogenesis was a result of Neurog3-
expressing ducts turning into new β-cells and it was shown that siRNA knock down of 
Neurog3 inhibited β-cell proliferation as well as their expansion (Xu et al., 2008).  Since 
then, however, Neurog3 has been found to be expressed by mature β-cells and actually to 
be required for their maturation and maintenance (Wang et al., 2009).  Therefore, it is 
possible that the β-cell expansion defect observed after Neurog3 knockdown is due to the 
functional role of Neurog3 in β-cells and not due to disrupted neogenesis. 
   Additionally, FACS analysis suggested that a 3-month-old pancreas contains 
~500,000 β-cells (Dor et al., 2004).  If we assume that ~200,000 β-cells are initially 
present in the ligated portion, this number should double to ~400,000 one week after 
PDL.  During embryogenesis, one Neurog3-expressing cell normally gives rise to only 
one endocrine cell (Desgraz and Herrera, 2009).  If we assume that this also applies to the 
PDL model, ~200,000 Neurog3+ cells are therefore needed to achieve doubling of beta-
cell mass.  The original PDL study by Xu et al. suggested that around 5000 Neurog3-
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expressing cells are present within one ligated pancreas at the 7 day time point, and of 
those 65% (3250 cells) were negative for endocrine markers (Xu et al., 2008).  To 
identify Neurog3+ cells, however, this study used a GFP reporter line instead of antibody 
staining.  Since the GFP protein has a long half-life, >24hrs (Li et al., 1998; Xu et al., 
2008), it is difficult to determine how many are actively expressing Neurog3 at any given 
time point between the surgery and the analysis.  Even if we assume that ~5000 
Neurog3+ cells are generated every day for 7 days (~40,000 cells), it is questionable 
whether this would be enough to cause doubling of β-cell mass.   
 Alternatively, neogenesis could indeed occur but at a frequency too low to be 
detected with any of the new Cre lines (Table 7.1).  If we assume that ~40,000 Neurog3+ 
ducts turned into new β-cells, we can make the following predictions of how many 
lineage-labeled islet cells we and others should have detected.  With our Muc1IC2 
(Chapter 2) and Hes1C2 (Chapters 3 and 4) lineages, between 10% and 20% of ducts were 
marked, respectively, so that around 4,000 to 8,000 Neurog3-derived β-cells should have 
carried the lineage label.  Even more duct labeling is seen with Hnf1bCreER (~ 40%) 
(Solar et al., 2009) and Sox9CreER (~60%) (Kopp et al., 2011), which should have 
resulted in labeling of around 20,000 β-cells.  Therefore, it seems unlikely that all Cre-
lines combined missed a potential duct-to- β-cell differentiation event.  The fact that 
Neurog3 expression within Sox9- and Muc1 lineage-derived ducts can be found but 
without detectable neogenesis (Chapter 2 and Kopp et al., 2011), rather suggests that 
Neurog3+ ducts do not adopt a β-cell fate after injury. 
 The possibility of a “missed” duct cell, which might be special, however, is 
always given when using the imperfect TM-CreERT system (Kushner et al., 2010).   
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Additionally, it is formally possible that a yet-unidentified duct population might exist, 
which represents a source for new β-cells but does not express any of the above 
mentioned markers.  Arguing against this hypothesis, several studies demonstrated that 
Sox9 (Kopp et al., 2011), Hnf1b (Solar et al., 2009) and Muc1 (Kopinke and Murtaugh, 
2010) are expressed throughout the ductal epithelium.  In addition, we stained ducts with 
different combinations of the above mentioned duct markers and found no difference 
between them.  It therefore seems questionable that all five different Cre lines used to 
analyze PDL missed a unique duct cell type, responsible for neogenesis.   
 Based on our arguments, we suggest that PDL does not cause neogenesis and it is 
doubtful whether β-cell mass actually increases during PDL.  One way of testing a 
potential increase in new β-cells after PDL would be to use ”pulse-chase” lineage tracing 
of pre-existing β-cells, which previously demonstrated that replication of these cells is 
the main mechanism for their postnatal expansion and maintenance (Brennand et al., 
2007; Dor et al., 2004; Teta et al., 2007). 
 In the third part of this thesis, we assessed the differentiation potential of Hes1+ 
cells in the embryonic and adult pancreas.  For this, we made use of a new Hes1C2 knock-
in allele that allows us to inducibly mark and trace Hes1+ cells and their descendants.  
Our lineage tracing studies indicate that Hes1 is indeed expressed in multipotent, Notch-
responsive progenitors, of the early embryonic pancreas, which give rise to all three 
major cell types.  At later embryonic stages, however, we find that Hes1 marks bipotent, 
exocrine-restricted progenitors.  In the adult pancreas, we confirmed earlier findings that 
Notch-Hes1 signaling is active in a subset of duct and centroacinar cells (CACs).  
Through long-term lineage labeling, however, we could show that, similar to Muc1+ 
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cells, Hes1+ duct cells do not generate β-cells after birth.  This observation also held true 
after PDL, suggesting that Hes1+ cells do not represent stem-like cells held in reserve for 
β-cell neogenesis during injury and regeneration (Chapter 5 and Fig. 7.1). 
 Finally, my finding that Notch promotes duct specification of exocrine-restricted 
progenitors in the embryo suggested that the differentiation status of adult Hes1+ cells 
might also be controlled by Notch.  By using a floxed deletion allele of RbpJ, which 
encodes the transcription factor partner through which Notch activates its target genes, 
we conditionally blocked Notch signaling in adult Hes1+ cells.  We found that acute loss 
of RbpJ in adult Hes1+ CACs causes their rapid transdifferentiation into acinar cells.  An 
acute pancreatitis injury model further indicates a physiological role for wild type CACs 
in assisting acinar cell regeneration (Chapter 6 and Fig. 7.1).  This finding is the first 
evidence of an endogenous genetic program to control interconversion of cell fates in the 
adult pancreas. 
 Although classical studies suggested that islet cells arise from ducts in the 
embryonic pancreas (Pictet and Rutter, 1972), it remained unclear whether these duct-like 
structures are truly the precursors of the adult ducts.  In addition, the contested question 
of whether adult duct cells ever give rise to islet cells could not be answered except 
through a genetic lineage-tracing approach.  This thesis utilized two novel mouse lines 
that, for the first time, permitted definitive lineage-tracing of embryonic and adult ducts 
to prove the ductal origin of embryonic islet cells and to refute the possibility of 
exocrine-to-endocrine conversion in the adult pancreas.  While converting the exocrine 
pancreas into new beta-cells could provide in principle an attractive method to treat 
human diabetes, the lack of an endogenous islet stem cell suggests that such an approach 
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will require genetic reprogramming of exocrine cells, either in vivo or in vitro (Cohen 
and Melton, 2011; Pan and Wright, 2011; Zhou et al., 2008).   
 This thesis also addressed the long-standing question whether the pancreas 
contains an adult stem/progenitor cell (Bonner-Weir and Weir, 2005).  While 
centroacinar cells have been proposed as a potential progenitor cell population (Rovira et 
al., 2010; Yanger and Stanger, 2011), our novel Hes1-Cre line provided the first in vivo 
evidence that these do indeed represent a facultative progenitor population in the adult 
pancreas.  We further showed that these cells utilize Notch signaling for maintenance of 
their undifferentiated state and that they contribute to new acinar cells following 
pancreatitis injury.  Notch signaling is not only required for successful regeneration after 
pancreatitis (Siveke et al., 2008) but is also implicated in pancreatic cancer (De La O et 
al., 2008).  We, therefore, hope that our work will not only help in the development of 
new cures for acute and chronic pancreatitis but also serve as a starting point to elucidate 
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